Sam Chawla, Director at VBI Vaccines Inc/BC (VBIV), bought 3,100,000 shares at $3.05 ($9.5M) on 2017-10-30, disclosed to the SEC on 2017-10-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |